Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - Enterprise Value over EBIT Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - EV/EBIT Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
|---|---|---|---|
| 6/30/2025 | $ -49.38M | $ 11.19M | 0 |
| 3/31/2025 | $ -51.27M | $ 2.36M | 0 |
| 12/31/2024 | $ -60.48M | $ -2.47M | 0 |
| 9/30/2024 | $ -66.33M | $ 19.44M | 0 |
| 6/30/2024 | $ -75.97M | $ 829.02K | 0 |
| 3/31/2024 | $ -85.27M | $ 13.71M | 0 |
| 12/31/2023 | $ -88.81M | $ 12.34M | 0 |
| 9/30/2023 | $ -73.94M | $ 26.33M | 0 |
| 6/30/2023 | $ -31.15M | $ 167.73M | 0 |
| 3/31/2023 | $ -46.02M | $ 170.1M | 0 |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average EV/EBIT has been 2.08.
- The median EV/EBIT for CARISMA THERAPEUTICS INC during this period was 2.08
- CARISMA THERAPEUTICS INC reached its highest EV/EBIT over the past 5 years at 2.08.
- The lowest EV/EBIT recorded by CARISMA THERAPEUTICS INC in the same timeframe 2.08
Similar metrics to EV/EBIT:
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Enterprise Value over EBIT
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].EV / EBIT
(=) EV/EBIT EV/EBIT for CARISMA THERAPEUTICS INC is calculated as follows: EV [ $ 101.58M ] / EBIT [ $ -39.81M ]
(=) EV/EBIT [ 0 ] CARM - Enterprise Value over EBIT, Last 5 years
2.08
Minimum
Jun 30, 2022
2.08
Maximum
Jun 30, 2022
2.08
Average
2.08
Median
EV/EBIT Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.9 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
| filtered constituents | 2.25K |
|---|---|
| min | 0.05 |
| max | 62.03 |
| average | 19.9 |
| median | 16.8 |
| std | 12.32 |